Evidence map›Paper›PMID 25181458›Full record

ArticleBiochemical pharmacology2014

c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.

Pankaj Chaudhary, Jamboor K Vishwanatha

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Tetrandrine for Targeting Therapy Resistance in Cancer.Current topics in medicinal chemistry · 2024
    Review
  5. Review
  6. Article
  7. Targeting the two-pore channel 2 in cancer progression and metastasis.Exploration of targeted anti-tumor therapy · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pankaj ChaudharyDepartment of Molecular and Medical Genetics, Texas Center for Health Disparities and Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Jamboor K VishwanathaDepartment of Molecular and Medical Genetics, Texas Center for Health Disparities and Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, TX 76107, USA. Electronic address: Jamboor.Vishwanatha@unthsc.edu.
University of North Texas · US

Funding

Triple Negative Breast Cancer: Novel Biomarkers and Therapeutic StrategiesP20MD006882 · NIMHD · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI GHORPADE, ANUJA · 2012 to 2016
$5.8M
NIMHD NIH HHS 1P20 MD006882NIMHD NIH HHS P20 MD006882
6 · The paper itself

Abstract

Tetrandrine, a constituent of Chinese herb Stephania tetrandra, causes cell death in prostate cancer, but the molecular mechanisms leading to apoptosis is not known. Here we demonstrated that tetrandrine selectively inhibits the growth of prostate cancer PC3 and DU145 cells compared to normal prostate epithelial PWR-1E cells. Tetrandrine-induced cell death in prostate cancer cells is caused by reactive oxygen species (ROS)-mediated activation of c-Jun NH2-terminal kinase (JNK1/2). JNK1/2-mediated proteasomal degradation of c-FLIPL/S and Bcl2 proteins are key events in the sensitization of prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine. Tetrandrine-induced JNK1/2 activation caused the translocation of Bax to mitochondria by disrupting its association with Bcl2 which was accompanied by collapse of mitochondrial membrane potential (MMP), cytosolic release of cytochrome c and Smac, and apoptotic cell death. Additionally, tetrandrine-induced JNK1/2 activation increased the phosphorylation of Bcl2 at Ser70 and facilitated its degradation via the ubiquitin-mediated proteasomal pathway. In parallel, tetrandrine-mediated ROS generation also caused the induction of ligand-independent Fas-mediated apoptosis by activating procaspase-8 and Bid cleavage. Inhibition of procaspase-8 activation attenuated the cleavage of Bid, loss of MMP and caspase-3 activation suggest that tetrandrine-induced Fas-mediated apoptosis is associated with the mitochondrial pathway. Furthermore, most of the signaling effects of tetrandrine on apoptosis were significantly attenuated in the presence of antioxidant N-acetyl-l-cysteine, thereby confirming the involvement of ROS in these events. In conclusion, the results of the present study indicate that tetrandrine-induced apoptosis in prostate cancer cells is initiated by ROS generation and that both intrinsic and extrinsic pathway contributes to cell death.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisBenzylisoquinolinesCASP8 and FADD-Like Apoptosis Regulating ProteinCell Line, TumorEnzyme ActivationHumansJNK Mitogen-Activated Protein KinasesMaleProstatic NeoplasmsProteasome Endopeptidase ComplexProteolysisProto-Oncogene Proteins c-bcl-2Antineoplastic Agents, PhytogenicBenzylisoquinolinesCASP8 and FADD-Like Apoptosis Regulating ProteinCFLAR protein, humanJNK Mitogen-Activated Protein KinasesProteasome Endopeptidase ComplexProto-Oncogene Proteins c-bcl-2tetrandrineApoptosisProstate cancerReactive oxygen speciesTetrandrineUbiquitination

Identifiers

PMID25181458
PMCPMC4171211
OpenAlexW2034530937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.